Tenaya Therapeutics, Inc.TNYANASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank50
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-68.26M
Near historical average
Percentile
P50
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-69.37M
Historical baseline
PeriodValueYoY Change
2025$-68.26M+24.6%
2024$-90.50M+11.3%
2023$-102.07M+2.3%
2022$-104.42M-71.7%
2021$-60.81M-71.6%
2020$-35.45M-47.1%
2019$-24.10M-